Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 3 studies | 18% ± 3% |
Insufficient scRNA-seq data for expression of CASP9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 6245.79 | 180 / 180 | 100% | 10.19 | 430 / 430 |
pancreas | 100% | 2317.50 | 328 / 328 | 100% | 11.25 | 178 / 178 |
prostate | 100% | 2171.65 | 245 / 245 | 100% | 13.44 | 502 / 502 |
thymus | 100% | 2938.98 | 653 / 653 | 100% | 15.32 | 605 / 605 |
uterus | 100% | 2293.56 | 170 / 170 | 100% | 13.27 | 459 / 459 |
brain | 100% | 1239.98 | 2639 / 2642 | 100% | 23.81 | 705 / 705 |
stomach | 100% | 1030.35 | 359 / 359 | 100% | 8.58 | 285 / 286 |
lung | 100% | 1200.56 | 576 / 578 | 100% | 11.32 | 1154 / 1155 |
adrenal gland | 100% | 4301.42 | 258 / 258 | 100% | 15.74 | 229 / 230 |
breast | 100% | 1033.11 | 459 / 459 | 100% | 10.33 | 1113 / 1118 |
esophagus | 100% | 1206.83 | 1445 / 1445 | 99% | 8.16 | 182 / 183 |
kidney | 100% | 1891.80 | 89 / 89 | 99% | 9.78 | 896 / 901 |
intestine | 100% | 1205.70 | 966 / 966 | 99% | 9.10 | 524 / 527 |
bladder | 100% | 1395.19 | 21 / 21 | 99% | 11.56 | 501 / 504 |
liver | 100% | 788.04 | 226 / 226 | 98% | 7.21 | 396 / 406 |
skin | 93% | 539.77 | 1691 / 1809 | 100% | 11.93 | 472 / 472 |
blood vessel | 100% | 1260.11 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.68 | 29 / 29 |
spleen | 100% | 1150.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.94 | 1 / 1 |
adipose | 99% | 1013.05 | 1197 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 7.68 | 79 / 80 |
muscle | 98% | 749.75 | 784 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 990.83 | 840 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 813.32 | 889 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008635 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c |
GO_0032355 | Biological process | response to estradiol |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0034349 | Biological process | glial cell apoptotic process |
GO_0002931 | Biological process | response to ischemia |
GO_0071549 | Biological process | cellular response to dexamethasone stimulus |
GO_0034644 | Biological process | cellular response to UV |
GO_0006974 | Biological process | DNA damage response |
GO_0016485 | Biological process | protein processing |
GO_0001822 | Biological process | kidney development |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
GO_0071887 | Biological process | leukocyte apoptotic process |
GO_0001666 | Biological process | response to hypoxia |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_1904019 | Biological process | epithelial cell apoptotic process |
GO_0006915 | Biological process | apoptotic process |
GO_0032025 | Biological process | response to cobalt ion |
GO_0044346 | Biological process | fibroblast apoptotic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0030220 | Biological process | platelet formation |
GO_0042770 | Biological process | signal transduction in response to DNA damage |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0051604 | Biological process | protein maturation |
GO_0008303 | Cellular component | caspase complex |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0043293 | Cellular component | apoptosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0008233 | Molecular function | peptidase activity |
GO_0097153 | Molecular function | cysteine-type endopeptidase activity involved in apoptotic process |
GO_0019901 | Molecular function | protein kinase binding |
GO_0097199 | Molecular function | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | CASP9 |
Protein name | Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10] Caspase 9 |
Synonyms | MCH6 |
Description | FUNCTION: Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates effector caspases caspase-3 (CASP3) or caspase-7 (CASP7). Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-ribose) polymerase (PARP). .; FUNCTION: [Isoform 2]: Lacks activity is an dominant-negative inhibitor of caspase-9. . |
Accessions | P55211 ENST00000447522.5 Q5JRU8 ENST00000375890.8 [P55211-4] ENST00000424908.5 ENST00000469637.1 ENST00000400777.7 ENST00000348549.9 [P55211-2] A0A087WX72 H0Y3S8 F8VWA5 Q5JRU2 ENST00000440484.1 ENST00000333868.10 [P55211-1] H0Y6Y2 ENST00000474305.2 F8VVS7 ENST00000546424.5 |